Search Results
Jun 03, 2026, 00:04 ET Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
(1) positive anti-double-stranded DNA (anti-dsDNA), (2) positive anti-Smith, (3) positive antinuclear antibodies (ANA) and positive for anti-Ro, anti-RNP or had a history of anti-dsDNA.f. Dr. Richard Furie has provided consulting, advisory and speaking services to Johnson & Johnson. He has not
More news about: Johnson & Johnson
May 27, 2026, 18:04 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
May 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on May 29, 2026 and cumulative distributions paid fiscal year-to-date.
More news about: Cohen & Steers REIT and Preferred Income Fund, Inc.
Apr 29, 2026, 18:05 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
April 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on April 30, 2026 and cumulative distributions paid fiscal year-to-date.
More news about: Cohen & Steers, Inc.
Mar 30, 2026, 16:00 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
March 30, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on March 31, 2026 and cumulative distributions paid fiscal year-to-date.
More news about: Cohen & Steers, Inc.
Mar 24, 2026, 17:06 ET Cohen & Steers Closed-End Funds Declare Distributions for April, May and June 2026
$0.110RNPCohen & Steers REIT and Preferred and Income
More news about: Cohen & Steers, Inc.
Feb 26, 2026, 18:26 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
Feb. 26, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on February 27, 2026 and cumulative distributions paid fiscal year-to-date.
More news about: Cohen & Steers
Feb 11, 2026, 20:00 ET ToolGen Enters 'Harvest Season' for Global IP Monetization; Appoints Litigation & Negotiation Expert Dave Koo as CLO
income and sustainable cash flow worldwide.EVP Yoori Kim, who leads ToolGen's IP business, has significantly strengthened the company's CRISPR RNP (Ribonucleoprotein) patent portfolio through 2025, equipping ToolGen with "decisive weaponry" for monetization. Furthermore, she established a dominant
More news about: ToolGen
Feb 11, 2026, 20:00 ET ToolGen betreedt 'oogstfase' voor wereldwijde IP-monetisatie en benoemt proces- en onderhandelingsexpert Dave Koo tot CLO
en duurzame kasstromen wereldwijd.EVP Yoori Kim, die verantwoordelijk is voor de IP-activiteiten van ToolGen, heeft tot en met 2025 het CRISPR RNP- (ribonucleoproteïne) patentportfolio van het bedrijf aanzienlijk versterkt. Daarmee heeft zij ToolGen voorzien van "doorslaggevende middelen" voor monetisatie.
More news about: ToolGen
Jan 27, 2026, 17:48 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
Jan. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on January 30, 2026 and cumulative distributions paid fiscal year-to-date.
More news about: Cohen & Steers, Inc.
Jan 05, 2026, 11:15 ET GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
clearance for our lead clinical asset, GEB-101, marks a momentous milestone in our commitment towards bringing transformative ribonucleoprotein (RNP)-based, ready-to-act and rapid degradation editor for one-and-done in vivo genome-editing therapy with high target tissue editing and low off-target editing
More news about: GenEditBio Limited
Jan 05, 2026, 03:15 ET GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
clearance for our lead clinical asset, GEB-101, marks a momentous milestone in our commitment towards bringing transformative ribonucleoprotein (RNP)-based, ready-to-act and rapid degradation editor for one-and-done in vivo genome-editing therapy to patients globally. This achievement reflects the concerted
More news about: GenEditBio Limited
Dec 18, 2025, 16:41 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
Dec. 18, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on December 31, 2025 and cumulative distributions paid fiscal year-to-date.
More news about: Cohen & Steers, Inc.
Dec 16, 2025, 17:34 ET Cohen & Steers Closed-End Funds Declare Distributions for January, February and March 2026
$0.110RNPCohen & Steers REIT and Preferred
More news about: Cohen & Steers, Inc.
Nov 26, 2025, 17:23 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
Nov. 26, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on November 28, 2025 and cumulative distributions paid fiscal year-to-date.
More news about: Cohen & Steers, Inc.
Nov 19, 2025, 09:00 ET ToolGen Completes U.S. Patent Registration for Core CRISPR Cas9 RNP Technology; Files U.S. Lawsuit Related to CASGEVY®
approach delivers Cas9 directly as a protein complexed with guide RNA (RNP), avoiding DNA/mRNA-related cytotoxicity, eliminating the risk of foreign DNA insertion, and improving safety through reduced off-target activity. CRISPR RNP delivery is widely used in therapeutic development as well as in animal
More news about: ToolGen
Oct 28, 2025, 17:00 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
Oct. 28, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on October 31, 2025 and cumulative distributions paid fiscal year-to-date
More news about: Cohen & Steers, Inc.
Sep 29, 2025, 17:39 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
Sept. 29, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on September 30, 2025 and cumulative distributions paid fiscal year-to-date.
More news about: Cohen & Steers, Inc.
Sep 23, 2025, 18:44 ET Cohen & Steers Closed-End Funds Declare Distributions for October, November and December 2025
$0.110 RNP Cohen & Steers REIT and Preferred and Income
More news about: Cohen & Steers, Inc.
Sep 08, 2025, 03:00 ET ToolGen reicht Klage wegen Patentverletzung gegen Lonza in den Niederlanden ein
ToolGen die Bedeutung seiner grundlegenden CRISPR-Cas9 RNP-Technologie unterstreichen und den Schutz seiner geistigen Eigentumsrechte stärken. „Hinter dem erfolgreichen kommerziellen Einsatz von CASGEVY spielt die proprietäre CRISPR-Cas9 RNP-Plattform von ToolGen eine zentrale Rolle", sagte
More news about: ToolGen
Sep 08, 2025, 03:00 ET ToolGen start octrooi-inbreukprocedure tegen Lonza in Nederland
wil ToolGen het belang van haar fundamentele CRISPR-Cas9 RNP-technologie onderstrepen en haar intellectuele eigendomsrechten in Europa krachtig beschermen. "Het succes van CASGEVY is mede mogelijk gemaakt door de unieke CRISPR-Cas9 RNP-technologie van ToolGen," aldus Jong
More news about: ToolGen
Sep 08, 2025, 03:00 ET ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands
reaffirm the importance of its foundational CRISPR-Cas9 RNP technology and strengthen protection of its intellectual property rights. "Behind the successful commercialization of CASGEVY lies the pivotal role of ToolGen's proprietary CRISPR-Cas9 RNP platform," said Jong Sang Ryu,
More news about: ToolGen
Sep 08, 2025, 03:00 ET ToolGen presenta demanda por infracción de patente contra Lonza en los Países Bajos
busca reafirmar la importancia de su tecnología fundamental CRISPR-Cas9 RNP y fortalecer la protección de sus derechos de propiedad intelectual. "Detrás del éxito comercial de CASGEVY está la plataforma propietaria CRISPR-Cas9 RNP de ToolGen, que juega un papel fundamental", dijo Jong
More news about: ToolGen
Sep 08, 2025, 03:00 ET ToolGen dépose une plainte pour violation de brevet contre Lonza aux Pays-Bas
réaffirmer l'importance de sa technologie fondamentale CRISPR-Cas9 RNP et renforcer la protection de sa propriété intellectuelle. « Le succès commercial de CASGEVY repose en grande partie sur notre plateforme propriétaire CRISPR-Cas9 RNP », a déclaré Jong Sang Ryu, PDG
More news about: ToolGen
Aug 28, 2025, 18:22 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
28, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on August 29, 2025 and cumulative distributions
More news about: Cohen & Steers, Inc.
Jul 30, 2025, 17:51 ET Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
30, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sources of the distribution to be paid on July 31, 2025 and cumulative distributions
More news about: Cohen & Steers, Inc.